Anti-vegf therapy and amd: The patient perspective

Diana V. Do, S. F. Patient

Research output: Contribution to journalComment/debatepeer-review

Abstract

The patient, SF, 79, was first diagnosed with the "wet" form of age-related macular degeneration (AMD) in 2004. She has since ridden a rollercoaster of emotions, ranging from devastation when a bleed in her left eye destroyed most of the vision there to ecstatic relief when use of intravitreal bevacizumab restored enough vision in the right eye to allow her to regain her driver's license. We interviewed the patient and her doctor, Diana V. Do, MD, Associate Professor of Ophthalmology, Retina Division at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, about the effect of AMD on quality of life.

Original languageEnglish (US)
Pages (from-to)16-18
Number of pages3
JournalJohns Hopkins Advanced Studies in Ophthalmology
Volume8
Issue number1
StatePublished - Oct 2011

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Anti-vegf therapy and amd: The patient perspective'. Together they form a unique fingerprint.

Cite this